Influenza News and Research

Latest Influenza News and Research

Life Technologies' real-time PCR instrument available for IVD use in Europe

Life Technologies Corporation (NASDAQ: LIFE) today announced that its Applied Biosystems 7500 Fast Dx Real-Time PCR Instrument is available as a platform suitable for in vitro diagnostics (IVD) use in Europe. Clinical laboratories from 22 countries and European institutions that develop in vitro molecular diagnostic assays in oncology, genetic disease and infectious disease will now be able to leverage the instrument’s regulatory clearance to develop tests for clinical applications.

24 Mar 2010

Washington State mercury-limit suspension for swine flu vaccine ends

When it comes to some diseases prevention still is better than cure and swine flu is one such disease. The sheer global panic that gripped nations last year is hard to forget. The PanvaxH1N1 vaccine is specifically manufactured to target the influenza (A) H1N1 strain known more popularly as swine flu. Getting the flu shots may be crucial in prevention of spread of the highly contagious disease. Health officials say that the H1N1 strain of flu is still circulating but at low levels.

24 Mar 2010

First reported Australian swine flu case of 2010 – gearing up with protective measures

Swine flu a form of influenza, became a major health scare assuming pandemic proportions starting in Mexico early last year. There were 37,000 confirmed cases in Australia with 5,000 hospitalizations, 700 admissions in intensive care units and 191 deaths.

23 Mar 2010

Chest x-rays may help identify high-risk H1N1 patients

A new study published in the April issue of Radiology suggests that chest x-rays may play an important role in the diagnosis and treatment of H1N1 influenza by predicting which patients are likely to become sicker.

23 Mar 2010

New understanding of cell in immune system may guide creation of effective flu vaccines: Study

A new understanding of a certain cell in the immune system may help guide scientists in creating better flu vaccines, report researchers from the Program in Cellular and Molecular Medicine and the Immune Disease Institute at Children's Hospital Boston.

23 Mar 2010

Pevion Biotech commences Phase 1 clinical trial of PEV7 vaccine

Pevion Biotech, the Swiss vaccine company, today announced that PEV7, the first vaccine for chronic recurrent thrush - recurrent vulvovaginal candidiasis has entered Phase 1 clinical trial.

22 Mar 2010

Zenyaku Kogyo receives license to Theraclone Sciences' influenza monoclonal antibody program

Theraclone Sciences, Inc., announced that Zenyaku Kogyo Co. Ltd., has exercised its option for an exclusive license in the Japan territory to Theraclone’s influenza monoclonal antibody program. The collaboration utilizes Theraclone’s I-STAR™ technology to discover broadly protective monoclonal antibodies for the treatment of pandemic influenza and severe seasonal influenza.

22 Mar 2010

Vical awarded contract to conduct Phase 1 clinical trial of Vaxfectin-formulated DNA vaccine against A/H1N1

Vical Incorporated announced today that the U.S. Navy, through the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., has awarded Vical a contract to conduct a Phase 1 clinical trial of the company's Vaxfectin®-formulated DNA vaccine against A/H1N1 pandemic influenza (swine flu).

22 Mar 2010

Researchers develop new compound to inhibit HIV transmission

A compound that can inhibit the transfer of HIV from one cell to another has been developed by researchers at the Institut de Biologie Structurale Jean-Pierre Ebel.

22 Mar 2010

Swine flu risk to pregnant women uncovered in landmark study

A study to be published in the British Medical Journal (BMJ) today has found 11 percent of pregnant women admitted to intensive care units (ICU) with 2009 A/H1N1 (swine flu) died, with 12 percent of babies born to them dying from complications. None of the mothers had been immunised against seasonal flu.

22 Mar 2010

Influenza pandemic policies: WHO denies being improperly influenced by pharmaceutical industry

Providing independent advice to Member States is a very important function of the World Health Organization (WHO). We take this work seriously and guard against the influence of any improper interests. The WHO influenza pandemic policies and response have not been improperly influenced by the pharmaceutical industry.

20 Mar 2010

ITDS can be effective for screening fever during H1N1 influenza pandemic: UNMC researchers

Researchers at the University of Nebraska Medical Center found an Infrared Thermal Detection System to be a fast and effective fever screening tool in clinical settings during the H1N1 influenza pandemic. The ITDS detected fever in patients through split-second, non-contact skin temperature measurements.

20 Mar 2010

Pressure BioSciences announces presentations on advantages of PCT

Pressure BioSciences, Inc. today announced that five presentations on the advantages of pressure cycling technology (PCT) in the preparation, processing, identification, and quantification of proteins were made at last week's annual meeting of US HUPO (Human Proteomics Organization) in Denver, Colorado.

From Thermo Fisher Scientific Inc. 19 Mar 2010

Activeion Cleaning Solutions announces new European subsidiary, Activeion GmbH

Activeion Cleaning Solutions LLC, Rogers, MN USA is proud to announce its new European subsidiary, Activeion (Europe) GmbH. Activeion (Europe) GmbH will distribute and market the ionator EXP™ throughout Europe, the Middle East and Africa. Activeion's ionator EXP™ is a handheld, on-demand, completely chemical-free cleaning tool that activates and converts tap water into ionised water, a powerful dirt-removing and bacteria-killing product.

19 Mar 2010

Genes role in protecting intestinal tract from colitis may lead to potential targets for treatment

Scientists report a protein made by a gene already associated with a handful of human inflammatory immune diseases plays a pivotal role in protecting the intestinal tract from colitis.

19 Mar 2010

Modulating body's inflammatory response may help fight serious infection

Treating virulent influenza, sepsis, and other potentially deadly infections long has focused on looking for ways to kill viruses and bacteria. But new research from the University of Utah and Utah State University shows that modulating the body's own overeager inflammatory response to infection may help save more lives.

18 Mar 2010

PPD, Southern Research Institute collaborate in pandemic and seasonal influenza vaccine research

PPD and Southern Research Institute today announced they have formed a collaborative agreement in pandemic and seasonal influenza vaccine research and development to provide clients a full spectrum of influenza vaccine development services by collaborating on client bids and projects.

18 Mar 2010

Simple common sense behaviors can help limit the spread of H1N1 in household: Study

Simple, common sense behaviors, including having a discussion at home about how to prevent influenza, can help limit the spread of H1N1 in a household, according to a study of the initial outbreak in New York City in 2009.

17 Mar 2010

Studies examine ways to increase healthcare personnel vaccination rates through social networking

Healthcare personnel influenza immunization rates have remained low, despite recommendations from the Centers for Disease Control and Prevention (CDC) and other leading healthcare organizations that all healthcare personnel receive annual flu vaccines.

17 Mar 2010

Can preventative vaccines curb the rising numbers of HIV cases?

According to a recent United Nations study, HIV infection rates among high-risk groups such as gays, drug users and sex workers are on the rise around the world.

17 Mar 2010

Influenza News and Research

Latest Influenza News and Research

Life Technologies' real-time PCR instrument available for IVD use in Europe

Washington State mercury-limit suspension for swine flu vaccine ends

First reported Australian swine flu case of 2010 – gearing up with protective measures

Chest x-rays may help identify high-risk H1N1 patients

New understanding of cell in immune system may guide creation of effective flu vaccines: Study

Pevion Biotech commences Phase 1 clinical trial of PEV7 vaccine

Zenyaku Kogyo receives license to Theraclone Sciences' influenza monoclonal antibody program

Vical awarded contract to conduct Phase 1 clinical trial of Vaxfectin-formulated DNA vaccine against A/H1N1

Researchers develop new compound to inhibit HIV transmission

Swine flu risk to pregnant women uncovered in landmark study

Influenza pandemic policies: WHO denies being improperly influenced by pharmaceutical industry

ITDS can be effective for screening fever during H1N1 influenza pandemic: UNMC researchers

Pressure BioSciences announces presentations on advantages of PCT

Activeion Cleaning Solutions announces new European subsidiary, Activeion GmbH

Genes role in protecting intestinal tract from colitis may lead to potential targets for treatment

Modulating body's inflammatory response may help fight serious infection

PPD, Southern Research Institute collaborate in pandemic and seasonal influenza vaccine research

Simple common sense behaviors can help limit the spread of H1N1 in household: Study

Studies examine ways to increase healthcare personnel vaccination rates through social networking

Can preventative vaccines curb the rising numbers of HIV cases?

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Influenza News and Research

Latest Influenza News and Research

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Newsletters you may be interested in